: alterations in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres more than the period from 2000 to 2012. Br J Ophthalmol. 2015;99:1531. 17. Weetman AP, Wiersinga WM. Current management of thyroid-associated ophthalmopathy in Europe. Outcomes of an international survey. Clin Endocrinol (Oxf). 1998;49:21. 18. Abraham-Nordling M, Bystr K, T ring O, Lantz M, Berg G, Calissendorff J, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011;165:89905.19. Zaletel K, Gaberscek S, Pirnat E. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J. 2011;52:6151. 20. Laurberg P, Berman DC, B ow Pedersen I, Andersen S, CarlA. Incidence and clinical presentation of moderate to extreme graves’ orbitopathy in a Danish population before and after iodine fortification of salt.Ketanserin J Clin Endocrinol Metab. 2012;97:23252. 21. Keiding N. Age-Specific Incidence and Prevalence: A Statistical Viewpoint. J R Stat Soc Ser A Stat Soc. 1991;154:37112. 22. Murray CJ, Lopez AD.TBB Quantifying disability: information, methods and benefits.PMID:24377291 Bull Planet Wellness Organ. 1994;72:4814. 23. Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models within the estimation of disease epidemiology. Bull Globe Health Organ. 2002;80:622. 24. http://www.who.int/healthinfo/global_burden_disease/tools_software/en/. Accessed 7 Jan 2017. 25. Brandt F, Almind D, Christensen K, Green A, Brix TH, Heged L. Excess mortality in hyperthyroidism: The influence of preexisting comorbidity and genetic confounding: A Danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab. 2012;97:4123. 26. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders inside the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:558. 27. Berglund J, Ericsson UB, Hallengren B. Elevated incidence of thyrotoxicosis in Malmduring the years 19880 as in comparison to the years 19704. J Intern Med. 1996;239:572. 28. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP. The thyroid epidemiology, audit and research study: thyroid dysfunction inside the common population. J Clin Endocrinol Metab. 2004;89:38794. 29. Termote K, Decallonne B, Mombaerts I. The influence of prior hyperthyroidism on euthyroid Graves’ Ophthalmopathy. J Ophthalmol. 2014;22:426898. 30. Eckstein AK, Glowacka D, Mann K, Esser J, Morgenthaler NG. Euthyroid and mostly hypothyroid patients create milder and drastically more asymmetrical Graves ophthalmopathy. Br J Ophthalmol. 2009;93:1052. 31. Khoo DH, Eng PH, Ho SC, Morgenthaler NG, Seah LL, Chee SP, et al. Graves’ ophthalmopathy in the absence of elevated free of charge thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000;10:109300. 32. Li Y, Kim J, Diana T, Klasen R, Olivo PD, Kahaly GJ. A novel bioassay for anti-thyrotrophin receptor autoantibodies detects each thyroid-blocking and stimulating activity. Clin Exp Immunol. 2013;173:390. 33. Ponto KA, Binder H, Diana T, Matheis N, Otto AF, Pitz S, et al. Prevalence, phenotype, and psychosocial well-being in euthyroid/hypothyroid thyroid-associated orbitopathy. Thyroid. 2015;25:942. 34. Soroudi AE, Goldberg RA, McCann JD. Prevalence of asymmetric exophthalmos in Graves’ orbitopathy. Ophthalmic Plast Reconstr Surg. 2004;20:224. 35. Wiersinga WM, Bleumink M, Saeed P, Baldeschi L, Prummel MF. Is sleeping position rel.
HIV gp120-CD4 gp120-cd4.com
Just another WordPress site
